NE
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$5.11
-0.78%
Mkt Cap $8.54M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | — | — | — | -$0.56 | -$0.77 | -37.50% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.55 | -$4.41 | -701.82% | — | — |
| Q3 2025 Sep 29, 2025 | $264.30K | -$15.66M | -6026.11% | -$0.56 | -$5.79 | -933.93% | — | — |
| Q2 2025 May 20, 2025 | $264.30K | $15.00M | +5575.36% | -$0.47 | $6.55 | +1493.62% | — | — |
| Q1 2025 Mar 17, 2025 | $264.30K | $662.60K | +150.70% | -$2.01 | -$0.01 | +99.59% | — | — |
| Q4 2024 Nov 15, 2024 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2024 Sep 30, 2024 | $1.77M | — | — | -$11.38 | -$29.16 | -156.21% | — | — |
| Q1 2024 Mar 31, 2024 | — | -$79.00K | — | — | -$0.02 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.03 | — | — | — |
| Q3 2023 Sep 30, 2023 | $3.14M | $5.48M | +74.48% | -$13.44 | -$0.01 | +99.96% | — | — |
| Q1 2023 Feb 23, 2023 | $2.90M | $214.74K | -92.59% | -$15.30 | -$17.64 | -15.30% | — | — |
| Q3 2022 Aug 25, 2022 | -$348.22K | $29.75K | +108.54% | -$15.35 | -$13.84 | +9.84% | — | — |
| Q1 2022 Feb 23, 2022 | $1.72M | — | — | -$8.76 | -$20.33 | -132.12% | — | — |